Bacterial Colonization Incidence before and after Indwelling Double-J Ureteral Stents.

antibiotic stewardship antibiotic susceptibility antibiotics antimicrobial resistance stenting upper urinary tract urinary tract infections

Journal

Antibiotics (Basel, Switzerland)
ISSN: 2079-6382
Titre abrégé: Antibiotics (Basel)
Pays: Switzerland
ID NLM: 101637404

Informations de publication

Date de publication:
24 Jun 2022
Historique:
received: 04 05 2022
revised: 21 06 2022
accepted: 22 06 2022
entrez: 27 7 2022
pubmed: 28 7 2022
medline: 28 7 2022
Statut: epublish

Résumé

The upper urinary tract stenting allows to restore the ureteral patency in various situations. However, one of the main disadvantages of stenting is bacterial contamination, which can be a source of persistent infections that hardly respond to antibiotic therapy. The aim of this study was to investigate the local spectrum of bacterial pathogens and their susceptibility to antibiotics in order to optimize antibacterial therapy after upper urinary tract stenting. A prospective observational study was conducted in which 140 urine samples were examined (70 before stenting and 70 after stenting). Bacterial growth was detected in 37 patients (52.8%) before stenting and in 43 patients (61.4%) after stenting.

Identifiants

pubmed: 35884104
pii: antibiotics11070850
doi: 10.3390/antibiotics11070850
pmc: PMC9312341
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : CSRD VA
ID : 1
Pays : United States

Références

J Urol. 2002 Mar;167(3):1334-7
pubmed: 11832726
Am J Infect Control. 2007 Jun;35(5):290-301
pubmed: 17577475
Int Urol Nephrol. 2007;39(1):95-8
pubmed: 17171409
Am J Med. 2017 Mar;130(3):e97-e98
pubmed: 27593612
Clin Microbiol Infect. 2012 Mar;18(3):268-81
pubmed: 21793988
Clin Microbiol Infect. 2001 Oct;7(10):532-42
pubmed: 11683793
Antimicrob Resist Infect Control. 2021 Jan 6;10(1):1
pubmed: 33407871
J Endourol. 2012 Feb;26(2):178-82
pubmed: 22007916
Curr Genet. 2013 Nov;59(4):251-64
pubmed: 23974350
Urology. 2007 Nov;70(5):846-50
pubmed: 18068437
J Urol. 2008 Feb;179(2):424-30
pubmed: 18076928
J Urol. 2005 Dec;174(6):2125-8
pubmed: 16280741
Urol Ann. 2018 Jan-Mar;10(1):71-75
pubmed: 29416279
Urol Int. 2018;101(3):320-326
pubmed: 30212821
Nat Rev Microbiol. 2015 May;13(5):269-84
pubmed: 25853778
J Pak Med Assoc. 2012 May;62(5):496-8
pubmed: 22755318
Urologiia. 2020 Mar;(1):19-31
pubmed: 32190999
Enferm Infecc Microbiol Clin. 2015 Jul;33 Suppl 2:34-9
pubmed: 26320994
Ann Med Health Sci Res. 2014 Jan;4(1):100-4
pubmed: 24669340
J Formos Med Assoc. 1990 Nov;89(11):1023-30, 1015
pubmed: 1982123
FEMS Microbiol Rev. 2012 Mar;36(2):380-407
pubmed: 22092265
Clin Microbiol Infect. 2018 Aug;24(8):865-870
pubmed: 29221995
Urology. 2003 Aug;62(2):214-7
pubmed: 12893321
BMJ Open. 2019 Jun 19;9(6):e028371
pubmed: 31221889
J Urol. 2016 Oct;196(4):1153-60
pubmed: 27238616
World J Urol. 2006 Dec;24(6):681-3
pubmed: 17094007
Int J Antimicrob Agents. 2001 Apr;17(4):259-68
pubmed: 11295405
Am J Med. 1986 Jun 30;80(6B):210-5
pubmed: 3728530
Urologiia. 2015 Jan-Feb;(1):94-8
pubmed: 26094396
Eur J Clin Microbiol Infect Dis. 2001 Mar;20(3):188-91
pubmed: 11347669
Int Urol Nephrol. 2014 Jun;46(6):1053-8
pubmed: 24366763
J Urol. 2004 Aug;172(2):592-5
pubmed: 15247739
Arch Ital Urol Androl. 2016 Jan 14;87(4):291-4
pubmed: 26766800
J Infect Dev Ctries. 2009 May 01;3(4):273-7
pubmed: 19759490

Auteurs

Sholpan Kaliyeva (S)

Department of Clinical Pharmacology and Evidence-Based Medicine, NCJSC Karaganda Medical University, Karaganda 100000, Kazakhstan.

Natalya Simokhina (N)

Department of Clinical Pharmacology and Evidence-Based Medicine, NCJSC Karaganda Medical University, Karaganda 100000, Kazakhstan.

Alyona Lavrinenko (A)

Scientific Research Laboratory, NCJSC Karaganda Medical University, Karaganda 100000, Kazakhstan.

Gulzira Zhussupova (G)

National Center for Rational Use of Medicines, Nur-Sultan 010000, Kazakhstan.

Serik Zhunusov (S)

Department of Surgery Diseases, NCJSC Karaganda Medical University, Karaganda 100000, Kazakhstan.

Polina Semenikhina (P)

Neurology, Psychiatry and Rehabilitation Department, NCJSC Karaganda Medical University, Karaganda 100000, Kazakhstan.

Yuliya Bikbatyrova (Y)

Department of Clinical Pharmacology and Evidence-Based Medicine, NCJSC Karaganda Medical University, Karaganda 100000, Kazakhstan.

Berik Yelmagambetov (B)

"SANAT" National Education Development Science Center, Nur-Sultan 010000, Kazakhstan.

Zhanna Myasnikova (Z)

Department of Clinical Pharmacology and Evidence-Based Medicine, NCJSC Karaganda Medical University, Karaganda 100000, Kazakhstan.

Classifications MeSH